Catalyst
Slingshot members are tracking this event:
PDUFA date set for March 29 2016 for Rayaldee in treating Secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) and vitamin D insufficiency
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
OPK |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 30, 2016
Occurred Source:
http://investor.opko.com/releasedetail.cfm?ReleaseID=962607
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Rayaldee, Secondary Hyperparathyroidism, Shpt, Chronic Kidney Disease, Ckd, Vitamin D Insufficiency, Fda, Nda, Pdufa